{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T20:58:15Z","timestamp":1775163495733,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Science Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-04599-9","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:35:04Z","timestamp":1765805704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Novel cationic peptide OB1111 is a dual anti-planktonic and anti-biofilm agent against P. aeruginosa strains PA14 and PAO1"],"prefix":"10.1186","volume":"26","author":[{"given":"Amber","family":"Grace","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Othreniel","family":"Forte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aguy","family":"Sipowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanella","family":"Tadjuidje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajnish","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald R.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vida A.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"4599_CR1","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1128\/JB.184.2.605-609.2002","volume":"184","author":"E Denamur","year":"2002","unstructured":"Denamur E, Bonacorsi S, Giraud A, Duriez P, Hilali F, Amorin C, et al. High frequency of mutator strains among human uropathogenic Escherichia coli isolates. J Bacteriol. 2002;184:605\u20139.","journal-title":"J Bacteriol"},{"key":"4599_CR2","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.274.5290.1208","volume":"274","author":"JE LeClerc","year":"1996","unstructured":"LeClerc JE, Li B, Payne WL, Cebula TA. High mutation frequencies among Escherichia coli and Salmonella pathogens. Science. 1996;274:1208\u201311.","journal-title":"Science"},{"key":"4599_CR3","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ijmm.2010.08.009","volume":"300","author":"A Oliver","year":"2010","unstructured":"Oliver A. Mutators in cystic fibrosis chronic lung infection: prevalence, mechanisms, and consequences for antimicrobial therapy. Int J Med Microbiol. 2010;300:563\u201372.","journal-title":"Int J Med Microbiol"},{"key":"4599_CR4","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.12667","volume":"10","author":"I Castillo-Juarez","year":"2022","unstructured":"Castillo-Juarez I, Blancas-Luciano BE, Garcia-Contreras R, Fernandez-Presas AM. Antimicrobial peptides properties beyond growth inhibition and bacterial killing. PeerJ. 2022;10:e12667.","journal-title":"PeerJ"},{"key":"4599_CR5","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3389\/fmicb.2015.01036","volume":"6","author":"L Freschi","year":"2015","unstructured":"Freschi L, Jeukens J, Kukavica-Ibrulj I, Boyle B, Dupont MJ, Laroche J, et al. Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium. Front Microbiol. 2015;6:1036.","journal-title":"Front Microbiol"},{"key":"4599_CR6","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1093\/gbe\/evz119","volume":"11","author":"EA Ozer","year":"2019","unstructured":"Ozer EA, Nnah E, Didelot X, Whitaker RJ, Hauser AR. The population structure of Pseudomonas aeruginosa is characterized by genetic isolation of exoU\u2009+\u2009and exoS\u2009+\u2009lineages. Genome Biol Evol. 2019;11:1780\u201396.","journal-title":"Genome Biol Evol"},{"key":"4599_CR7","volume-title":"Methods for Dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M07-A9","author":"Institute CaLS","year":"2012","unstructured":"Institute CaLS. Methods for Dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M07-A9. 9th ed. Wayne (PA): CLSI; 2012.","edition":"9"},{"key":"4599_CR8","volume-title":"Methods for determining bactericidal activity of antimicrobial agents: approved guideline M26-A","author":"Institute CaLS","year":"1999","unstructured":"Institute CaLS. Methods for determining bactericidal activity of antimicrobial agents: approved guideline M26-A. Wayne (PA): CLSI; 1999."},{"key":"4599_CR9","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1038\/s41596-021-00515-3","volume":"16","author":"EF Haney","year":"2021","unstructured":"Haney EF, Trimble MJ, Hancock REW. Microtiter plate assays to assess antibiofilm activity against bacteria. Nat Protoc. 2021;16:2615\u201332.","journal-title":"Nat Protoc"},{"key":"4599_CR10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.mimet.2014.07.024","volume":"105","author":"P Sabaeifard","year":"2014","unstructured":"Sabaeifard P, Abdi-Ali A, Soudi MR, Dinarvand R. Optimization of tetrazolium salt assay for Pseudomonas aeruginosa biofilm using microtiter plate method. J Microbiol Methods. 2014;105:134\u201340.","journal-title":"J Microbiol Methods"},{"key":"4599_CR11","volume-title":"Protocol for bacterial biofilm visualization and sample Preparation for scanning electron microscopy","author":"MFS Cardoso","year":"2024","unstructured":"Cardoso MFS. Protocol for bacterial biofilm visualization and sample Preparation for scanning electron microscopy. Leeuwarden, the Netherlands: ibidi GmbH; 2024."},{"key":"4599_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2022.105654","volume":"169","author":"P Mishra","year":"2022","unstructured":"Mishra P, Ch S, Hong SJ, Biswas S, Roy S. Antimicrobial peptide S100A12 (calgranulin C) inhibits growth, biofilm formation, pyoverdine secretion and suppresses type VI secretion system in Pseudomonas aeruginosa. Microb Pathog. 2022;169:105654.","journal-title":"Microb Pathog"},{"key":"4599_CR13","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1128\/IAI.69.9.5385-5394.2001","volume":"69","author":"PJ Wilderman","year":"2001","unstructured":"Wilderman PJ, Vasil AI, Johnson Z, Wilson MJ, Cunliffe HE, Lamont IL, et al. Characterization of an endoprotease (PrpL) encoded by a PvdS-regulated gene in Pseudomonas aeruginosa. Infect Immun. 2001;69:5385\u201394.","journal-title":"Infect Immun"},{"key":"4599_CR14","doi-asserted-by":"publisher","first-page":"1557664","DOI":"10.3389\/fmicb.2025.1557664","volume":"16","author":"A Grace","year":"2025","unstructured":"Grace A, Sahu R, Owen DR, Dennis VA. Host-mimicking conditions promote Pseudomonas aeruginosa PA14 virulence gene expression. Front Microbiol. 2025;16:1557664.","journal-title":"Front Microbiol"},{"key":"4599_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-020-0803-x","volume":"3","author":"A Khondker","year":"2020","unstructured":"Khondker A, Rheinstadter MC. How do bacterial membranes resist polymyxin antibiotics? Commun Biol. 2020;3:77.","journal-title":"Commun Biol"},{"key":"4599_CR16","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1128\/AAC.44.12.3317-3321.2000","volume":"44","author":"L Zhang","year":"2000","unstructured":"Zhang L, Dhillon P, Yan H, Farmer S, Hancock RE. Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2000;44:3317\u201321.","journal-title":"Antimicrob Agents Chemother"},{"key":"4599_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ebiom.2017.05.026","volume":"20","author":"SC Ersoy","year":"2017","unstructured":"Ersoy SC, Heithoff DM, Barnes Lt, Tripp GK, House JK, Marth JD, Smith JW, Mahan MJ. Correcting a fundamental flaw in the paradigm for antimicrobial susceptibility testing. EBioMedicine. 2017;20:173\u201381.","journal-title":"EBioMedicine"},{"key":"4599_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13578-017-0164-4","volume":"7","author":"C Castells-Sala","year":"2017","unstructured":"Castells-Sala C, Martorell J, Balcells M. A human plasma derived supplement preserves function of human vascular cells in absence of fetal bovine serum. Cell Biosci. 2017;7:41.","journal-title":"Cell Biosci"},{"key":"4599_CR19","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/s41598-020-80540-6","volume":"11","author":"WH Tang","year":"2021","unstructured":"Tang WH, Wang CF, Liao YD. Fetal bovine serum albumin inhibits antimicrobial peptide activity and binds drug only in complex with alpha1-antitrypsin. Sci Rep. 2021;11:1267.","journal-title":"Sci Rep"},{"key":"4599_CR20","doi-asserted-by":"publisher","first-page":"171311","DOI":"10.1016\/j.peptides.2024.171311","volume":"182","author":"E Imperlini","year":"2024","unstructured":"Imperlini E, Massaro F, Grifoni A, Maiurano F, Taddei AR, Borocci S, Buonocore F, Porcelli F. Membrane alteration, anti-virulence properties and metabolomic perturbation of a chionodracine-derived antimicrobial peptide, KHS-Cnd, on two bacteria models. Peptides. 2024;182:171311.","journal-title":"Peptides"},{"key":"4599_CR21","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.3389\/fmicb.2017.01707","volume":"8","author":"D Kang","year":"2017","unstructured":"Kang D, Kirienko NV. High-throughput genetic screen reveals that early attachment and biofilm formation are necessary for full pyoverdine production by Pseudomonas aeruginosa. Front Microbiol. 2017;8:1707.","journal-title":"Front Microbiol"},{"key":"4599_CR22","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s40265-021-01635-6","volume":"81","author":"D Reynolds","year":"2021","unstructured":"Reynolds D, Kollef M. The epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa infections: an update. Drugs. 2021;81:2117\u201331.","journal-title":"Drugs"},{"key":"4599_CR23","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00031-19","author":"JP Horcajada","year":"2019","unstructured":"Horcajada JP, Montero M, Oliver A, Sorli L, Luque S, Gomez-Zorrilla S, et al. Epidemiology and treatment of multidrug-resistant and extensively drug-resistant <Emphasis Type=\"Italic\">Pseudomonas aeruginosa<\/Emphasis> infections. Clin Microbiol Rev. 2019. https:\/\/doi.org\/10.1128\/CMR.00031-19.","journal-title":"Clin Microbiol Rev"},{"key":"4599_CR24","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1093\/cid\/ciy378","volume":"67","author":"SS Kadri","year":"2018","unstructured":"Kadri SS, Adjemian J, Lai YL, Spaulding AB, Ricotta E, Prevots DR, et al. Difficult-to-treat resistance in Gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents. Clin Infect Dis. 2018;67:1803\u201314.","journal-title":"Clin Infect Dis"},{"key":"4599_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","volume":"37","author":"Z Pang","year":"2019","unstructured":"Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv. 2019;37:177\u201392.","journal-title":"Biotechnol Adv"},{"key":"4599_CR26","doi-asserted-by":"publisher","first-page":"582779","DOI":"10.3389\/fmicb.2020.582779","volume":"11","author":"Y Huan","year":"2020","unstructured":"Huan Y, Kong Q, Mou H, Yi H. Antimicrobial peptides: classification, design, application and research progress in multiple fields. Front Microbiol. 2020;11:582779.","journal-title":"Front Microbiol"},{"key":"4599_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3389\/fphar.2018.00281","volume":"9","author":"A Pfalzgraff","year":"2018","unstructured":"Pfalzgraff A, Brandenburg K, Weindl G. Antimicrobial peptides and their therapeutic potential for bacterial skin infections and wounds. Front Pharmacol. 2018;9:281.","journal-title":"Front Pharmacol"},{"key":"4599_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0005-2736(99)00198-4","volume":"1462","author":"RM Epand","year":"1999","unstructured":"Epand RM, Vogel HJ. Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophys Acta. 1999;1462:11\u201328.","journal-title":"Biochim Biophys Acta"},{"key":"4599_CR29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","volume":"10","author":"MS Mulani","year":"2019","unstructured":"Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR. Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review. Front Microbiol. 2019;10:539.","journal-title":"Front Microbiol"},{"key":"4599_CR30","doi-asserted-by":"publisher","first-page":"1023523","DOI":"10.3389\/fmicb.2022.1023523","volume":"13","author":"A Grace","year":"2022","unstructured":"Grace A, Sahu R, Owen DR, Dennis VA. Pseudomonas aeruginosa reference strains PAO1 and PA14: a genomic, phenotypic, and therapeutic review. Front Microbiol. 2022;13:1023523.","journal-title":"Front Microbiol"},{"key":"4599_CR31","doi-asserted-by":"publisher","unstructured":"LaBauve AE, Wargo MJ. Growth and laboratory maintenance of Pseudomonas aeruginosa. Curr Protoc Microbiol Chap 6: 2012. Unit 6E 1. Corrected citation from PubMed: LaBauve AE, Wargo MJ. (2012). Growth and laboratory maintenance of Pseudomonas aeruginosa. Current protocols in microbiology, Chapter 6, Unit\u20136E.1. https:\/\/doi.org\/10.1002\/9780471729259.mc06e01s25.","DOI":"10.1002\/9780471729259.mc06e01s25"},{"key":"4599_CR32","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1038\/s41598-022-06640-7","volume":"12","author":"WH Tang","year":"2022","unstructured":"Tang WH, Wang SH, Wang CF, Mou Y, Lin MG, Hsiao CD, Liao YD. The lipid components of high-density lipoproteins (HDL) are essential for the binding and transportation of antimicrobial peptides in human serum. Sci Rep. 2022;12:2576.","journal-title":"Sci Rep"},{"key":"4599_CR33","doi-asserted-by":"publisher","first-page":"1352339","DOI":"10.3389\/fcimb.2024.1352339","volume":"14","author":"N Lyons","year":"2024","unstructured":"Lyons N, Wu W, Jin Y, Lamont IL, Pletzer D. Using host-mimicking conditions and a murine cutaneous abscess model to identify synergistic antibiotic combinations effective against Pseudomonas aeruginosa. Front Cell Infect Microbiol. 2024;14:1352339.","journal-title":"Front Cell Infect Microbiol"},{"key":"4599_CR34","doi-asserted-by":"publisher","first-page":"32855","DOI":"10.1021\/acsami.2c05979","volume":"14","author":"R Garcia Maset","year":"2022","unstructured":"Garcia Maset R, Hapeshi A, Hall S, Dalgliesh RM, Harrison F, Perrier S. Evaluation of the antimicrobial activity in Host-Mimicking media and in vivo toxicity of antimicrobial polymers as functional mimics of AMPs. ACS Appl Mater Interfaces. 2022;14:32855\u201368.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4599_CR35","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1007\/s00018-011-0710-x","volume":"68","author":"AT Yeung","year":"2011","unstructured":"Yeung AT, Gellatly SL, Hancock RE. Multifunctional cationic host defence peptides and their clinical applications. Cell Mol Life Sci. 2011;68:2161\u201376.","journal-title":"Cell Mol Life Sci"},{"key":"4599_CR36","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tibtech.2011.05.001","volume":"29","author":"LT Nguyen","year":"2011","unstructured":"Nguyen LT, Haney EF, Vogel HJ. The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol. 2011;29:464\u201372.","journal-title":"Trends Biotechnol"},{"key":"4599_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan4044","author":"A de Breij","year":"2018","unstructured":"de Breij A, Riool M, Cordfunke RA, Malanovic N, de Boer L, Koning RI, et al. The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Sci Transl Med. 2018. https:\/\/doi.org\/10.1126\/scitranslmed.aan4044.","journal-title":"Sci Transl Med"},{"key":"4599_CR38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.15698\/mic2023.11.807","volume":"10","author":"S Yang","year":"2023","unstructured":"Yang S, Li X, Cang W, Mu D, Ji S, An Y, Wu R, Wu J. Biofilm tolerance, resistance and infections increasing threat of public health. Microb Cell. 2023;10:233\u201347.","journal-title":"Microb Cell"},{"key":"4599_CR39","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jmii.2016.12.005","volume":"50","author":"PY Chung","year":"2017","unstructured":"Chung PY, Khanum R. Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria. J Microbiol Immunol Infect. 2017;50:405\u201310.","journal-title":"J Microbiol Immunol Infect"},{"key":"4599_CR40","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1093\/jac\/dkw143","volume":"71","author":"LP Lashua","year":"2016","unstructured":"Lashua LP, Melvin JA, Deslouches B, Pilewski JM, Montelaro RC, Bomberger JM. Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells. J Antimicrob Chemother. 2016;71:2200\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"4599_CR41","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12866-023-02886-x","volume":"23","author":"S Masihzadeh","year":"2023","unstructured":"Masihzadeh S, Amin M, Farshadzadeh Z. In vitro and in vivo antibiofilm activity of the synthetic antimicrobial peptide WLBU2 against multiple drug resistant Pseudomonas aeruginosa strains. BMC Microbiol. 2023;23:131.","journal-title":"BMC Microbiol"},{"key":"4599_CR42","doi-asserted-by":"publisher","first-page":"753874","DOI":"10.3389\/fmicb.2021.753874","volume":"12","author":"L Moll","year":"2021","unstructured":"Moll L, Badosa E, Planas M, Feliu L, Montesinos E, Bonaterra A. Antimicrobial peptides with antibiofilm activity against xylella fastidiosa. Front Microbiol. 2021;12:753874.","journal-title":"Front Microbiol"},{"key":"4599_CR43","doi-asserted-by":"publisher","first-page":"6953","DOI":"10.1038\/s41598-017-07440-0","volume":"7","author":"MF Mohamed","year":"2017","unstructured":"Mohamed MF, Brezden A, Mohammad H, Chmielewski J, Seleem MN. A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and acinetobacter baumannii. Sci Rep. 2017;7:6953.","journal-title":"Sci Rep"},{"key":"4599_CR44","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.3389\/fmicb.2019.02866","volume":"10","author":"N Raheem","year":"2019","unstructured":"Raheem N, Straus SK. Mechanisms of action for antimicrobial peptides with antibacterial and antibiofilm functions. Front Microbiol. 2019;10:2866.","journal-title":"Front Microbiol"},{"key":"4599_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201900840","volume":"7","author":"X Liu","year":"2020","unstructured":"Liu X, Liu F, Ding S, Shen J, Zhu K. Sublethal levels of antibiotics promote bacterial persistence in epithelial cells. Adv Sci. 2020;7:1900840.","journal-title":"Adv Sci"},{"key":"4599_CR46","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrmicro3270","volume":"12","author":"DI Andersson","year":"2014","unstructured":"Andersson DI, Hughes D. Microbiological effects of sublethal levels of antibiotics. Nat Rev Microbiol. 2014;12:465\u201378.","journal-title":"Nat Rev Microbiol"},{"key":"4599_CR47","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.molcel.2010.01.027","volume":"37","author":"BB Kaufmann","year":"2010","unstructured":"Kaufmann BB, Hung DT. The fast track to multidrug resistance. Mol Cell. 2010;37:297\u20138.","journal-title":"Mol Cell"},{"key":"4599_CR48","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau5480","author":"BP Lazzaro","year":"2020","unstructured":"Lazzaro BP, Zasloff M, Rolff J. Antimicrobial peptides: application informed by evolution. Science. 2020. https:\/\/doi.org\/10.1126\/science.aau5480.","journal-title":"Science"},{"key":"4599_CR49","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.3389\/fmicb.2019.01160","volume":"10","author":"AS Vasilchenko","year":"2019","unstructured":"Vasilchenko AS, Rogozhin EA. Sub-inhibitory effects of antimicrobial peptides. Front Microbiol. 2019;10:1160.","journal-title":"Front Microbiol"},{"key":"4599_CR50","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1128\/AAC.46.3.605-614.2002","volume":"46","author":"A Patrzykat","year":"2002","unstructured":"Patrzykat A, Friedrich CL, Zhang L, Mendoza V, Hancock RE. Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob Agents Chemother. 2002;46:605\u201314.","journal-title":"Antimicrob Agents Chemother"},{"key":"4599_CR51","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/978-1-4939-0473-0_24","volume":"1149","author":"F Hoegy","year":"2014","unstructured":"Hoegy F, Mislin GL, Schalk IJ. Pyoverdine and pyochelin measurements. Methods Mol Biol. 2014;1149:293\u2013301.","journal-title":"Methods Mol Biol"},{"key":"4599_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2020.129606","volume":"1864","author":"A Di Somma","year":"2020","unstructured":"Di Somma A, Avitabile C, Cirillo A, Moretta A, Merlino A, Paduano L, et al. The antimicrobial peptide Temporin L impairs E. coli cell division by interacting with FtsZ and the divisome complex. Biochimica et Biophysica Acta (BBA). 2020;1864:129606.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"4599_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22063128","author":"I Jurado-Martin","year":"2021","unstructured":"Jurado-Martin I, Sainz-Mejias M, McClean S. Pseudomonas aeruginosa: an audacious pathogen with an adaptable arsenal of virulence factors. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22063128.","journal-title":"Int J Mol Sci"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04599-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-04599-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04599-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T13:02:26Z","timestamp":1769173346000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-025-04599-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4599"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-04599-9","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"D.R.O. is the President and CEO of Owen Biosciences Inc. and is holding, or currently applying for, patents relating to the content of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}